BHC News and Press, Bausch Health Companies Inc. From 01/23/26

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials Canada NewsWire LAVAL, QC , Jan. 23, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the results of the global Phase 3 RED-C clinical program evaluating amorphous-rifaximin sol...

Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 Canada NewsWire LAVAL, QC , Jan. 21, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2025 financial results after market close ...

2026-01-15 03:15:58 ET Bausch Health Companies Inc. (BHC) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 6:45 PM EST... Read the full article on Seeking Alpha For further details see: Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Heal...

2026-01-13 10:54:37 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path Why Bausch Health Is A Buy After Rising 10% On ...

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference Canada NewsWire LAVAL, QC , Jan. 5, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Thomas J. Appio , Chief Executive Officer, will participate at the 44 th...

2026-01-02 16:52:07 ET More on Bausch + Lomb, Bausch Health Companies Bausch + Lomb: I Need To See Stability Before Upgrading This Name Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript Bau...

LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary 1261229 B.C. Ltd. (the "Issuer" and, together with the Company, the "Offerors") today announced the final results and expiration of their previously announced o...

2025-12-21 22:03:28 ET This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 11/14/2025. Please visit our Tracking John ...

2025-12-18 21:04:54 ET This article is part of a series that provides an ongoing analysis of the changes made to Carl Icahn’s 13F portfolio on a quarterly basis. It is based on Icahn’s regulatory 13F Form filed on 11/14/2025. Please visit our Tracking Carl Icahn ...

LAVAL, QC / ACCESS Newswire / December 8, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") announced today the results to date of its previously announced offers to exchange the Company's outstanding 4.875% Senior Secured Notes due 2028 (the "4.875% Notes") and 11.00% Se...